Antimicrobial agent/phenotype | 2008 cohort (n = 135) | Prevalence (95% CI) | 2017 cohort (n = 187) | Prevalence (95% CI) | % change | Total (%) | P value |
---|---|---|---|---|---|---|---|
Amoxicillin (%) | 135 | 100 (97.2–100) | 187 | 100 (98.0–100) | 0 | 322 (100) | 1.0 † |
Cefpodoxime (%) | 130 | 96.3 (91.6–98.4) | 187 | 100 (98.0–100) | + 3.7 | 317 (98.4) | 0.01† |
Ceftiofur (%) | 123 | 91.1 (85.1–94.8) | 182 | 97.3 (93.9–98.9) | + 6.2 | 305 (94.7) | 0.03 |
Gentamicin (%) | 118 | 87.4 (80.8–92.0) | 181 | 96.8 (93.2–98.5) | + 9.4 | 299 (92.9) | 0.0026 |
TMPS (%) | 133 | 98.5 (94.8–99.6) | 159 | 85.0 (79.2–89.4) | −13.5 | 292 (90.7) | < 0.001 |
Doxycycline (%) | 53 | 39.3 (31.4–47.7) | 172 | 92.0 (87.2–95.1) | + 52.7 | 225 (69.9) | < 0.001 |
Enrofloxacin (%) | 36 | 26.7 (19.9–34.7) | 62 | 33.2 (26.8–40.2) | + 6.5 | 98 (30.4) | 0.3 |
MDR (%) | 120 | 88.9 (82.5–93.2) | 176 | 94.1 (89.8–96.7) | + 5.2 | 296 (91.9) | 0.1 |